EUVIMEDEUVIMED entdecken
FallberichtLeserbrief

Familial chylomicronemia syndrome: a novel mutation in the lipoprotein lipase gene

S Van Biervliet, S Vande Velde, P De Bruyne, B Callewaert, P Verloo, R De Bruyne

Acta Gastro Enterologica Belgica · 2024

DOI: 10.51821/87.2.12025 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Acta Gastro Enterologica Belgica, 2024. Verfasst von S Van Biervliet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric gastroenterology, hepatology and nutrition department, Ghent University Hospital, Ghent, Belgium. Hauptthemen laut MEDLINE: Lipoprotein Lipase, Hyperlipoproteinemia Type I, Mutation. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial chylomicronemia syndrome (FCS) (OMIM: 238600) is a rare autosomal recessive disease caused by a biallelic loss-of-function mutation in the lipoprotein lipase (LPL) complex which includes LPL and its co-factors. Patients with FCS have severe hypertiglyceridemia (> 2000 mg/dL). We describe a 15-month-old boy with repeated pancreatitis episodes caused by severe hypertriglyceridemia. Genetic analysis revealed a novel homozygous mutation in the LPL gene, i.e. c.626T>G; p.(Leu209*). The mutation, carried by both parents, has been classified as a type 4 mutation which is likely pathogenic. Treatment aims at decreasing hypertriglyceridaemia by a low-fat diet (< 20g/day) eventually supplemented with medium chain triglyceride (MCT) fat to ensure caloric intake. In 2019, volanesorsen was approved by the European Medicines Agency (EMA) as adjunct treatment for adult patients with genetically proven FCS and persisting episodes of pancreatitis despite the diet.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein LipaseHyperlipoproteinemia Type IMutationHumansMaleFemale

Stichwörter der Autor:innen

childchylomicronemiahyper-triglyceridemialipoprotein lipasepancreatitis

Substanzen

Lipoprotein Lipase

Autor:innen und Institutionen

  • Pediatric gastroenterology, hepatology and nutrition department, Ghent University Hospital, Ghent, Belgium.
  • Center for medical genetics, Ghent University Hospital, Ghent, Belgium.
  • Center for metabolic diseases, Ghent University Hospital, Ghent, Belgium.

Zitieren

APA

Van Biervliet, S., Vande Velde, S., De Bruyne, P., Callewaert, B., Verloo, P., & De Bruyne, R. (2024). Familial chylomicronemia syndrome: a novel mutation in the lipoprotein lipase gene. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/87.2.12025

Vancouver

Van Biervliet S, Vande Velde S, De Bruyne P, Callewaert B, Verloo P, De Bruyne R. Familial chylomicronemia syndrome: a novel mutation in the lipoprotein lipase gene. Acta Gastro Enterologica Belgica. 2024. doi:10.51821/87.2.12025

BibTeX
@article{VanBiervliet2024,
  author = {Van Biervliet, S and Vande Velde, S and De Bruyne, P and Callewaert, B and Verloo, P and De Bruyne, R},
  title = {Familial chylomicronemia syndrome: a novel mutation in the lipoprotein lipase gene},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2024},
  doi = {10.51821/87.2.12025}
}
Kostenlos starten →